Prosecution Insights
Prosecution Insights
Tech Center 3600 • Art Units: 1616 1629 3642
This examiner grants 30% of resolved cases
Susannah Sipple Armstrong is an examiner in Tech Center 3600 and Art Unit 1616. With 29 resolved cases, she has an allowance rate of 31.0 percent. This 31.0 percent rate indicates the frequency of granted patents among the 29 resolved cases. Practitioners can use these figures to evaluate the prosecution environment and the likelihood of success in this specific unit.
The interview lift is 52.5 percent, which is a statistic that shows the change in allowance probability following an interview. This 52.5 percent lift is a notable metric for developing a strategy. The median days to allowance is 1171, providing a benchmark for the time required to reach a grant. This 1171-day median is a key data point for managing expectations. These figures from Tech Center 3600 and Art Unit 1616 serve as the basis for understanding the examiner's historical performance and the duration of the prosecution cycle.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18444627 | CELLULOSE PARTICLE | Final Rejection | FUJIFILM Business Innovation Corp. |
| 18755788 | Oral Care Compositions Comprising Hops Beta Acids | Non-Final OA | The Procter & Gamble Company |
| 18825202 | AGRICULTURAL COMPOSITION AND METHOD FOR CULTIVATING PLANTS USING SAME | Non-Final OA | KANEKA CORPORATION |
| 18853592 | ADAPTIVE PATCHES FOR DYNAMIC ORGANS | Non-Final OA | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
| 18836156 | COMPOSITIONS AND METHODS FOR ENHANCED DRUG LOADING OF LONG-ACTING IN SITU FORMING IMPLANTS AND USES THEREOF | Non-Final OA | The University of North Carolina at Chapel Hill |
| 17801705 | EUTECTIC BASED ANESTHETIC COMPOSITIONS AND APPLICATIONS THEREOF | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18489193 | ENHANCED YEASTICIDAL EFFICACY OF LACTIC ACID BASED ANTIMICROBIAL HANDWASH | Non-Final OA | ECOLAB USA INC. |
| 18691863 | LIPIODOL FORMULATION FOR TRANSARTERIAL CHEMOIMMUNOEMBOLIZATION | Final Rejection | Northwestern University |
| 18566802 | NON-CONTACT LITHOTRIPSY USING PHOTONIC NANOPARTICLES | Non-Final OA | The Cleveland Clinic Foundation |
| 18505079 | MICROCAPSULE AND PREPARATION METHOD AND USE THEREOF | Final Rejection | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18499201 | NATURE-BASED FACIAL LIFTING MASK | Final Rejection | L'OREAL |
| 18004734 | WATER-IN-OIL EMULSION HAVING A HIGH INTERNAL WATER PHASE CONTENT | Non-Final OA | L'OREAL |
| 18278677 | COATED MEDICAL DEVICE AND PRODUCTION METHOD THEREFOR | Non-Final OA | TORAY Industries, Inc. |
| 18686557 | Multi-Layered Dextrose Tablets | Non-Final OA | Fertin Pharma A/S |
| 18286890 | RESHAPING COMPOSITION FOR KERATIN FIBERS | Non-Final OA | KAO GERMANY GMBH |
| 18552034 | PICKERING EMULSIONS STABILIZED BY PARTICLES | Final Rejection | Firmenich SA |
| 18285017 | COMPOSITION FOR TREATING A KERATINOUS SURFACE | Non-Final OA | Givaudan SA |
| 18714147 | METHOD FOR PREPARING ORAL COMPOSITE TABLET CONTAINING PROTON PUMP INHIBITOR AND ANTACID AND ORAL COMPOSITE TABLET PREPARED THEREBY | Non-Final OA | HANMI PHARM. CO., LTD. |
| 17798029 | COMPOSITION FOR ELECTROSPINNING | Final Rejection | BAKEL S.R.L. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy